Fatty Liver Treatment Growth Trajectory: Key Forecasts and Strategic Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#What Are the Projected Market Size and Growth Rates for the Fatty Liver Treatment Market From 2025 To 2029?#_x000D_
The market size for fatty liver treatment has witnessed considerable growth in the past few years. It is projected to increase from $23.73 billion in 2024 to $25.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.5%. The growth witnessed during the historic period is owed to factors such as the obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment choices, and heightened awareness campaigns._x000D_
_x000D_
The market size for treatments of fatty liver is predicted to witness substantial growth in the forthcoming years, reaching$32.98 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%. This growth during the projection period is largely due to the rise in the prevalence of the disease, increased spending on healthcare, expansion of diabetes and metabolic syndrome, as well as therapeutic innovations. Key trends during this forecast period include precise medical procedures, lifestyle change programs, specifically designed therapies for Nash, non-invasive monitoring equipment, and advancements in technology._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp_x000D_
_x000D_
#Which Factors and External Forces Are Driving Demand in the Fatty Liver Treatment Market?#_x000D_
The upsurge in alcohol intake is anticipated to boost the fatty liver treatment market’s expansion. The term “alcohol consumption” refers to the intake of drinks that contain alcohol, a psychoactive substance with sedative effects on the central nervous system. If the consumption of alcohol is not controlled, it can exacerbate fatty liver disease and result in more serious liver conditions, such as alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For example, the HRB National Drugs Library, a government-funded organization in Ireland, reported in March 2023 that alcohol consumption in Scotland rose to 10.2 liters of pure alcohol per capita for individuals over the age of 15 in 2022. This figure represents a 7.6% increase from 2021, and signifies a worrying increase in alcohol consumption, despite public health attempts to curb intake. Consequently, the elevation in alcohol consumption is the driving force behind the fatty liver treatment market’s growth._x000D_
_x000D_
#Which Segments in the Fatty Liver Treatment Offer the Most Growth?#_x000D_
The fatty liver treatmentmarket covered in this report is segmented – _x000D_
_x000D_
1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants; Chemotherapy Drugs; Targeted Therapy; Vaccines; Anti-Viral Drugs_x000D_
2) By Disease Type: Hepatitis; Liver Cancer; Non-Alcoholic Fatty Liver Disease; Other Diseases_x000D_
3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids; Calcineurin Inhibitors; mTOR Inhibitors _x000D_
2) By Chemotherapy Drugs: Conventional Chemotherapy Agents; Novel Chemotherapeutics Under Investigation _x000D_
3) By Targeted Therapy: Small Molecule Inhibitors; Monoclonal Antibodies _x000D_
4) By Vaccines: Therapeutic Vaccines; Preventive Vaccines _x000D_
5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs); Nucleos(t)ide Analogs _x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=12581&type=smp_x000D_
_x000D_
#What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Fatty Liver Treatment Market?# Market?#_x000D_
North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Which Cutting-Edge Market Trends Are Expected to Drive theFatty Liver Treatment Market’s Growth?#_x000D_
The emergence of product innovation is an increasingly prevalent trend in the fatty liver treatment market. Established companies in this sector are creating novel products to consolidate their market position. For instance, Akero Therapeutics, a biotechnology company from the United States, released encouraging Phase II results of efruxifermin, a drug developed for non-invasively diagnosed nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), in March 2023. Efruxifermin, a unique Fc-FGF21 fusion protein, replicates the biological function of fibroblast growth factor 21 (FGF21) which controls various metabolic pathways and cellular activities._x000D_
_x000D_
#View the full report here:#_x000D_
https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report_x000D_
_x000D_
#What Are the Key Elements That Define the Fatty Liver Treatment Market?#_x000D_
Fatty liver disease is a condition in which fat builds up in the liver, causing various symptoms and complications. Fatty liver treatment refers to the multiple strategies, interventions, and actions to address and manage fatty liver disease. _x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12581_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
